Sign in
4

Changes in Ownership

Amneal Pharmaceuticals, Inc. Filed Acc 0001628280-24-020741

Options or other derivatives

  • Director acquired 40,258 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Patel Gautam Director 2024-05-02 Grant or award · Restricted Stock Units +40,258 40,258 D
Loading xslF345X05/wk-form4_1715031344.xml…